Adjuvant imatinib for GIST: duration likely matters

Annals of Oncology ◽

10.1016/j.annonc.2021.01.073 ◽

2021 ◽

Author(s):

M. Eriksson ◽

H. Joensuu

Keyword(s):

Adjuvant Imatinib

Download Full-text

Faculty Opinions recommendation of Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725906529.793535661 ◽

2017 ◽

Author(s):

Florence Duffaud

Keyword(s):

High Risk ◽

Randomized Trial ◽

Stromal Tumor ◽

Adjuvant Imatinib ◽

Gi Stromal Tumor

Download Full-text

Delayed adjuvant imatinib in patients with high risk of recurrence of gastrointestinal stromal tumor after radical surgery: a retrospective cohort study

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03749-6 ◽

2021 ◽

Author(s):

Wan Qianyi ◽

Xu Mei ◽

Zhao Rui ◽

Wang Yong ◽

Wu Yutao ◽

...

Keyword(s):

Cohort Study ◽

High Risk ◽

Gastrointestinal Stromal Tumor ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Radical Surgery ◽

Stromal Tumor ◽

Adjuvant Imatinib ◽

Risk Of Recurrence

Download Full-text

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

Annals of Surgical Oncology ◽

10.1245/s10434-011-2190-5 ◽

2011 ◽

Vol 19 (4) ◽

pp. 1074-1080 ◽

Author(s):

Dian Wang ◽

Qiang Zhang ◽

Charles D. Blanke ◽

George D. Demetri ◽

Michael C. Heinrich ◽

...

Keyword(s):

Radiation Therapy ◽

Gastrointestinal Stromal Tumors ◽

Phase Ii Trial ◽

Radiation Therapy Oncology Group ◽

Oncology Group ◽

Adjuvant Imatinib ◽

Stromal Tumors ◽

Long Term Follow Up

Download Full-text

That's the “GIST” of It: Use of Adjuvant Imatinib After Resection of a Primary GI Stromal Tumor

Journal of Clinical Oncology ◽

10.1200/jco.2013.53.5971 ◽

2014 ◽

Vol 32 (15) ◽

pp. 1543-1546 ◽

Author(s):

William D. Tap ◽

Gary K. Schwartz

Keyword(s):

Stromal Tumor ◽

Adjuvant Imatinib ◽

It Use ◽

Gi Stromal Tumor

Download Full-text

A Cost-Effectiveness Analysis of Three Years of Adjuvant Imatinib in Kit+ Gastrointestinal Stromal Tumors (GIST) in Greece

Annals of Oncology ◽

10.1016/s0923-7534(20)33285-3 ◽

2012 ◽

Vol 23 ◽

pp. ix236

Author(s):

M. Raikou ◽

I. Boukovinas ◽

M. Geitona

Keyword(s):

Cost Effectiveness ◽

Gastrointestinal Stromal Tumors ◽

Cost Effectiveness Analysis ◽

Adjuvant Imatinib ◽

Stromal Tumors ◽

Effectiveness Analysis

Download Full-text

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors

JAMA Oncology ◽

10.1001/jamaoncol.2020.2091 ◽

2020 ◽

Vol 6 (8) ◽

pp. 1241 ◽

Author(s):

Heikki Joensuu ◽

Mikael Eriksson ◽

Kirsten Sundby Hall ◽

Annette Reichardt ◽

Barbara Hermes ◽

...

Keyword(s):

High Risk ◽

Gastrointestinal Stromal Tumors ◽

Survival Outcomes ◽

Adjuvant Imatinib ◽

Download Full-text

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Yearbook of Gastroenterology ◽

10.1016/s0739-5930(09)79325-0 ◽

2009 ◽

Vol 2009 ◽

pp. 150-151 ◽

Author(s):

D.T. Dempsey

Keyword(s):

Imatinib Mesylate ◽

Controlled Trial ◽

Gastrointestinal Stromal Tumour ◽

Stromal Tumour ◽

Adjuvant Imatinib ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors

Techniques in Coloproctology ◽

10.1007/s10151-013-0976-0 ◽

2013 ◽

Vol 17 (5) ◽

pp. 571-574 ◽

Author(s):

D. Centonze ◽

E. Pulvirenti ◽

A. Pulvirenti D’Urso ◽

S. Franco ◽

N. Cinardi ◽

...

Keyword(s):

Local Excision ◽

Gastrointestinal Stromal Tumors ◽

Imatinib Therapy ◽

Adjuvant Imatinib ◽

Download Full-text

Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand

Cost Effectiveness and Resource Allocation ◽

10.1186/s12962-018-0169-9 ◽

2019 ◽

Vol 17 (1) ◽

Author(s):

Thanaporn Bussabawalai ◽

Kittiphong Thiboonboon ◽

Yot Teerawattananon

Keyword(s):

High Risk ◽

Gastrointestinal Stromal Tumour ◽

Cost Utility ◽

Cost Utility Analysis ◽

Stromal Tumour ◽

Imatinib Treatment ◽

Adjuvant Imatinib ◽

Utility Analysis ◽

Risk Of Recurrence

Download Full-text

Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib

JAMA Oncology ◽

10.1001/jamaoncol.2016.5751 ◽

2017 ◽

Vol 3 (5) ◽

pp. 602 ◽

Author(s):

Heikki Joensuu ◽

Eva Wardelmann ◽

Harri Sihto ◽

Mikael Eriksson ◽

Kirsten Sundby Hall ◽

...

Keyword(s):

Gastrointestinal Stromal Tumors ◽

Adjuvant Imatinib ◽

Download Full-text